Determination of tolbutamide and hydroxytolbutamide by LC–MS/MS in rat and its application to assessment of CYP2C9 activity by Qiu, Xiangjun et al.
999ISSN 0326-2383
KEY WORDS: CYP, Hydroxytolbutamide, LC-MS/MS, Rat, Tolbutamide.
* Author to whom correspondence should be addressed. E-mail: xurenai1986@163.com
Latin American Journal of Pharmacy
(formerly Acta Farmacéutica Bonaerense)
Lat. Am. J. Pharm. 31 (7): 999-1004 (2012)
Regular Article
Received: June 29, 2012
Revised version: August 19, 2012
Accepted: August 20, 2012
Determination of Tolbutamide and Hydroxytolbutamide by LC–MS/MS
in Rat and its Application to Assessment of CYP2C9 Activity
Xiangjun QIU 1, Ai-li FEI 2, Zhisheng XU 3, Xiaoxiang DU 2, Haiyan ZHU 2 & Ren-ai XU 2*
1 Department of Pharmacology, Medical College of Henan University of Science and Technology,
Luoyang, 471003, China
2 The First Affiliated Hospital of Wenzhou Medical College, Wenzhou 325000, China
3 The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325000, China
SUMMARY. A sensitive and selective liquid chromatography–tandem mass spectrometry method
(LC–MS/MS) for the determination of tolbutamide (TB) and its metabolite hydroxytolbutamide (HTB) in
rat plasma was developed using carbamazepine as an internal standard. Chromatographic separation was
performed by an Agilent Zorbax SB-C18 column (150 mmx2.1 mm, 3.5 μm), using the gradient elution of
0.1 % formic acid in water and acetonitrile. Calibration plots were linear over range of 5–1000 ng/mL for
TB and 10–2000 ng/mL for HTB in rat plasma. The intra- and inter-day relative standard deviations of
the assay were less than 10 % for both TB and HTB. The validated method is successfully used to analyze
the influence of bupropion on cytochrome P450-mediated metabolism of TB. The biotransformation rates
of TB administered either separately or both simultaneously were compared in this study. The results re-
vealed that bupropion had no significant effect on TB hydroxylation. 
